Shah Medico Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 02-07-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.80 Cr
as on 02-07-2024
- Satisfied Charges ₹ 20.15 Cr
as on 02-07-2024
- Revenue 39.75%
(FY 2023)
- Profit 194.27%
(FY 2023)
- Ebitda -318.15%
(FY 2023)
- Net Worth 2.24%
(FY 2023)
- Total Assets 1.86%
(FY 2023)
About Shah Medico
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹7.80 Cr. The company has closed loans amounting to ₹20.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Shah, Swapnil Shah, and Paresh Shah serve as directors at the Company.
- CIN/LLPIN
U24232PN2002PTC017278
- Company No.
017278
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shah Medico?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Shah  | Director | 09-Sep-2002 | Current |
| Swapnil Shah | Director | 18-May-2006 | Current |
| Paresh Shah | Director | 09-Sep-2002 | Current |
Financial Performance of Shah Medico.
Shah Medico Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.75% increase. The company also saw a substantial improvement in profitability, with a 194.27% increase in profit. The company's net worth moved up by a moderate rise of 2.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shah Medico?
In 2023, Shah Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shah Medicals (Pune) Private LimitedActive 22 years 3 monthsRajesh Shah, Swapnil Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2023 | ₹5.00 M | Open |
Others Creation Date: 08 Oct 2020 | ₹3.00 M | Open |
Others Creation Date: 20 Feb 2020 | ₹7.00 Cr | Open |
How Many Employees Work at Shah Medico?
Shah Medico has a workforce of 12 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shah Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shah Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
